AU687554B2 - An analyzing apparatus and method - Google Patents
An analyzing apparatus and method Download PDFInfo
- Publication number
- AU687554B2 AU687554B2 AU23322/95A AU2332295A AU687554B2 AU 687554 B2 AU687554 B2 AU 687554B2 AU 23322/95 A AU23322/95 A AU 23322/95A AU 2332295 A AU2332295 A AU 2332295A AU 687554 B2 AU687554 B2 AU 687554B2
- Authority
- AU
- Australia
- Prior art keywords
- sampling chamber
- organ
- interest
- fluid
- tonometric catheter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title claims abstract description 18
- 238000005070 sampling Methods 0.000 claims abstract description 67
- 239000012530 fluid Substances 0.000 claims abstract description 61
- 239000007789 gas Substances 0.000 claims abstract description 34
- 210000000056 organ Anatomy 0.000 claims abstract description 23
- 210000001835 viscera Anatomy 0.000 claims abstract description 16
- 238000004891 communication Methods 0.000 claims abstract description 10
- 206010022680 Intestinal ischaemia Diseases 0.000 claims abstract description 8
- 208000025865 Ulcer Diseases 0.000 claims abstract description 5
- 230000036269 ulceration Effects 0.000 claims abstract description 5
- 238000001514 detection method Methods 0.000 claims abstract description 4
- 239000007788 liquid Substances 0.000 claims description 26
- 239000000463 material Substances 0.000 claims description 14
- 230000002485 urinary effect Effects 0.000 claims description 9
- 241000124008 Mammalia Species 0.000 claims description 8
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 8
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 6
- 230000005669 field effect Effects 0.000 claims description 6
- 230000003287 optical effect Effects 0.000 claims description 5
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 claims description 4
- 229920001971 elastomer Polymers 0.000 claims description 4
- 239000000806 elastomer Substances 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 230000002496 gastric effect Effects 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 239000001569 carbon dioxide Substances 0.000 claims description 2
- 239000013536 elastomeric material Substances 0.000 claims description 2
- 239000012466 permeate Substances 0.000 claims description 2
- 229920000728 polyester Polymers 0.000 claims description 2
- WOZVHXUHUFLZGK-UHFFFAOYSA-N dimethyl terephthalate Chemical compound COC(=O)C1=CC=C(C(=O)OC)C=C1 WOZVHXUHUFLZGK-UHFFFAOYSA-N 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 239000004020 conductor Substances 0.000 abstract description 8
- 210000004379 membrane Anatomy 0.000 description 16
- 239000012528 membrane Substances 0.000 description 16
- 238000005286 illumination Methods 0.000 description 11
- 239000000835 fiber Substances 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- 238000005259 measurement Methods 0.000 description 7
- 239000004065 semiconductor Substances 0.000 description 7
- 230000002262 irrigation Effects 0.000 description 5
- 238000003973 irrigation Methods 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 4
- 229910052721 tungsten Inorganic materials 0.000 description 4
- 239000010937 tungsten Substances 0.000 description 4
- 239000013543 active substance Substances 0.000 description 3
- 210000001072 colon Anatomy 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 239000007793 ph indicator Substances 0.000 description 3
- -1 polydimethylsiloxane Polymers 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000002620 ureteric effect Effects 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000001139 pH measurement Methods 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 239000012730 sustained-release form Substances 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 208000028399 Critical Illness Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000034486 Multi-organ failure Diseases 0.000 description 1
- 208000010718 Multiple Organ Failure Diseases 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 208000029744 multiple organ dysfunction syndrome Diseases 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000000287 tissue oxygenation Effects 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14539—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring pH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/1459—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1473—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/42—Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/42—Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems
- A61B5/4222—Evaluating particular parts, e.g. particular organs
- A61B5/4255—Intestines, colon or appendix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6852—Catheters
- A61B5/6853—Catheters with a balloon
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Optics & Photonics (AREA)
- Endocrinology (AREA)
- Physiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Electrotherapy Devices (AREA)
- External Artificial Organs (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Plant Substances (AREA)
- Executing Machine-Instructions (AREA)
- Saccharide Compounds (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
Abstract
A remote sensing tonometric catheter apparatus (20) and method for sampling of a fluid or gas property of interest in a hollow internal organ. The tonometric catheter (20) assists in early detection of the problems of stress ulceration and/or intestinal ischemia. The tonometric catheter (20) has one or more sampling chambers (40) for introduction into a hollow internal organ or an area adjacent thereto. The tonometric catheter (20) has an electric sensor (42) for developing a signal indicative of the condition of the organ. Electric sensor (42) is in communication with the sampling chamber (40). The sensor (42) has a conductor (56) coupled therewith for conveying the signal to a location outside the organ such that the condition of the organ may be remotely determined. Preferably, the wall (36) of the sampling chamber (40) is freely permeable to the gas or fluid to be measured by the sensor (42), but is poorly permeable to other gases or fluids which may interfere with the sensor (42). The method is accomplished by introducing the catheter into the organ such that the sampling chamber is disposed at a portion of the wall of the organ. The sampling chamber is left in position at the wall of the organ for a time sufficient to allow the fluid or gas of interest to diffuse into the sampling chamber. The concentration of the fluid or gas of interest is analyzed. The pH of the wall of the organ may be calculated based on the concentration of the fluid or gas property of interest.
Description
AUSTRALIA
PATENTS ACT 1990 COMPLETE SPECIFICATION FOR A STANDARD PATENT (Original)
I
Name of Applicant/Nominated Person: Mountpelier Investments S.A.
Actual Inventor(s): Richard, FIDDIAN-GREEN Address for Service: DAVIES COLLISON CAVE, Patent Attorneys, 1 Little Collins Street, Melbourne, 3000.
Invention Title: "An Analyzing Apparatus and Method" The following statement is a full description of this invention, including the best method of performing it known to us: 950629,qAopcrkny,4 0162-93.180,1 I AN ANALYZING APPARATUS AND METHOD This invention relates to medical diagnostic equipment and methods and is particularly concerned with hollow viscus tonometry and remote electronic and optical sensing.
The prior art (see U.S. Patent No. 4,643,192) has recognized that intestinal ischemia, and to a lesser degree, stress ulceration, are two problems that plague physicians involved in the management of patients in intensive care units.
Intestinal ischemia, in particular, has an insidious onset and may not be detected until days after the intestine has become completely and irreversibly compromised. A delay in the diagnosis of intestinal ischemia may have devastating consequences for a patient. The availability of means for early S. 15 diagnosis and management of patients with these problems would S have immediate applicability in all intensive care units, especially where the procedure can be conveniently conducted with reasonable safety and reliability.
It has been established that a fall in the intramucosal pH may precede the development of intestinal ischemia and stress ulceration. As I reported in my prior U.S. Patent No. 4,643,192, expressly incorporated herein by reference, entitled "Hollow Viscus Tonometry" a fall in intramucosal pH also occurs within minutes of inducing intestinal ischemia in dogs. The fall in pH 25 in intestinal mucosa, and hence the likelihood of ischemia or S stress ulceration, can be reliably calculated from a pCO 2 (partial pressure of CO2), or other indicia of pH, in luminal fluid and the bicarbonate concentration in arterial blood. The method of calculating the pH in intestinal mucosal tissue, pursuant to principles of my prior patent, has been validated by directed measurements under a variety of conditions simulating clinical problems. A correlation coefficient in the order of 0.92 to 0.95 has been obtained in each of 16 dogs. The validity of the procedure is inherently extensible to humans, and indeed may also be useful in assessing the vitality of other hollow I I~ar~ll~a~rr~ asaru~-~r~ or:ans and tissue. See R.G. Fiddian-Gree; et al. "Splanchnic Ischemia and Multiple Organ Failure".
To measure the pCO 2 in the lumen of the gut it has heretofore been necessary to obtain and remove a sample of fluid that has been in contact with the wall of the gut for a certain ti=e period, usually at least half an hour. It has now been observed that it is somewhat difficult to manually aspirate the sampling fluid or medium from a tonometric catheter located in the gut o- other i ternal focus with any consistency. It is much :0 easier to obtain such samples from the stomach, but samples obtained from the stomach frequently contain foreign material that can damage a gas analyzer.
As taught in my prior patent, the desired sample or samples can be obtained from the gut using a catheter tube 1" 5 (called a tonometric catheter) having a walled sampling chamber on the tube with the sampling chamber being in sample-specific communication with the hollow interior of the tube. The wall of S the sampling chamber comprises a material which is substantially impermeable to liquid yet is highly permeable to gas. One suitable material is polydimethylsiloxane elastomer.
In use the catheter is introduced into a patient to place the sampling chamber at a desired site within the gut. An aspirating liquid or medium is employed to fill the interior of the sampling chamber. The sampling chamber is left in place at the desired sampling site long enough to allow the gases present tc diffuse through the wall of the sampling chamber into the aspirating liquid. The time should be long enough for the gases to equilibrate. The liquid impermeable nature of the sample chamber wall material prevents both the aspirating liquid from leaking out of the chamber and also the intrusion of any liquids into the aspirating liquid. After the appropriate or desired atount of placement time has elapsed the aspirating liquid is aspirated along with the gases which have diffused into it. The sample thus obtained is analyzed for gas content, in particular for pCO 2 In this way the pCO 2 within the lumen of the gut can be reliably measured with the fluid being free from lumenal debris.
I
I I I Y I III 14 11 1 -3- In carrying out the diagnostic method taught in my prior patent the pCO 2 measurement is utilized in conjunction with a measurement of the bicarbonate ion concentration (HC03j) in an arterial blood sample of the patient for determining the pH of the tract wall.
Depending upon the particular condition of a given patient, the catheter may be left in place and samples may be taken at periodic intervals so that pH values may be periodically calculated. The procedure has a high reliability in accurately I determining the adequacy of organ tissue oxygenation, and diagnosing intestinal ischemia in its incipient stages. Such determination or detection can be useful in treating the patient so that the potentially devastating consequences resulting from less timely detection may often be avoided.
While the sampling techniques taught in my prior patent have provided highly accurate and reliable results, it has now been observed that there are instances (in the care of the critically ill in intensive care units, for example) in which o remote sensing of the organ or organ-wall condition and automatic calculation of the organ or organ-wall pH would be S.advantageous and easier to effectuate. This method would thus "partially or totally eliminate the need for the somewhat cumbersome aspiration of the sampling fluid or medium which fills the sampling chamber; it may also eliminate the need for the sampling chamber to be in sampling-medium communication with any other part of the device. There is also a need to extend the benefits of tonometric sampling and sensing to other internal hollow viscous organs. To this end, there is a need for new and different tonometric devices specifically adapted to allow my sensing and sampling techniques to be performed with ease in a clinical environment, and in combination with other procedures.
According to the present invention there is provided a tonometric catheter and secondary apparatus for measuring a liquid fluid or gaseous fluid property indicative of the condition of an internal organ of a human or other mammal in
-I
1 1, 1. 1 2 I 1 19 1 *II -4vivo, comprising: a) an elongated tube having a tonometric catheter lumen extending longitudinally therethrough, said tube being composed of a first elastomeric material that is substantially S impermeable to one or more liquid fluids or gaseous fluids of interest, said fluids of interest including oxygen gases and carbon dioxide gases; b. at least one walled sampling chamber on said tube in fluid communication with the interior of said tonometric I) catheter lumen, said walled sampling chamber being defined by a balloon member generally siurrounding a portion of said tube and sealingly interconnected therewith, the wall of said balloon member being composed of a second material that is freely and selectively permeable to said one or more liquid fluids or gaseous fluids of interest, said second material being substantially impermeable to other liquid fluids or gaseous fluids, and said balloon member being inflated for forming an interior space between said balloon member and said tonometric catheter lumen and for selectively positioning a portion of said balloon member substantially in direct contact with a wall portion of the internal organ in order to allow said one or more liquid fluids or gaseous fluids of interest from the tissue of the wall portion of the internal organ to permeate into said sampling chamber, with said tube extending to a position outside 25 of the body of the human or other mammal, and with said tonometric catheter lumen providing fluid communication between :said sampling chamber and the outside of the body of the human or other mammal; c) sensor means for sensing the level of at least one of said liquid fluids or gaseous fluids of interest from the tissue of the wall portion of the internal organ present within said sampling chamber, said sensor means being disposed within said sampling chamber; and said secondary apparatus including a second lumen extending longitudinally through said tube and being adapted for the delivery or draining of a liquid or gaseous fluid to or from I i I1n i' I Mk 1. P I N' i4 1 1 -1 4A the internal organ.
For a more complete understanding of embodiments of the invention, its objects and advantages, reference may be had to the following specification and to the accompanying drawings.
Also, see my co-pending and commonly assigned applications filed of even date herewith entitled "Tonometric Catheter Combination" and "Hollow Viscus and Solid Organ Tonometry", bearing respective serial numbers WO 90/01893 and WO 90/01896, both of which are completely and expressly incorporated herein by I) reference.
Embodiments of the invention will now be described, by way of example only, with reference to the accompanying drawings, in which: e See 1111~ Figure 1 is a plan view of a tonometric catheter; Figure 2A is a partial cross-sectional view of the tonometric catheter illustrating a first means for attachment of an electronic field effect transistor sensor; Figure 2B is a partial cross-sectional view of the tonometric catheter illustrating a second means of attachment of the field effect transistor sensor; Figure 3 illustrates the method of use of the tonometric catheter in measurement of the pH of the colon and also of the stomach, the specific embodiment illustrated for colonic measurement being that of Figure 5 and the specific tonometric catheter for gastric measurement being that of 5 Figure 4; Figure 4 is another embodiment of the tonometric Scatheter with nasogastric tube; Figure 4A is a cross-sectional view of the tonometric catheter of Figure 4 taken substantially along the line 4A-4A of Figure 4; Figure 4B is a cross-sectional view of the tonometric S catheter of Figure 4 taken substantially along the line 4B-4B of Figure 4; Figure 5 is yet another embodiment of the tonometric catheter having multiple sensing/sampling portions; Figure 5A is a cross-sectional view of the tonometric catheter of Figure 5, taken substantially along the line 5A-5A of Figure Figure 6 is a detailed view illustrating the tonometric catheter of Figure 4 in use within the stomach; Figure 7 is a detailed view illustrating the tonometric catheter of Figure 5 in use within the colon; Figure 8 is a similar View illustrating the tonometric catheter of Figure 1 in use within the colon; Figure 9 is an electrical schematic diagram -1, Figure 10 is an electrical schematic diagram illustrating the optical measurement of pH; Figure 11 is another embodiment of a tonometric catheter with a urinary catheter; Figure 11A is a cross-sectional view of the tonometric catheter/urinary catheter of Figure 11, taken substantially along the line lIA-11A of Figure 11 and Figure 12 is a schematic assembly view of the apparatus.
Figure 1 illustrates a first embodiment of tonometric catheter 20. The tonometric catheter comprises a length of suitable tubing 22, one end 32 of which is closed, and the opposite end of which has a connector such as a luer-lock 24.
Luer-lock 24 is adapted to receive a complementary fitting 26, which in turn couples through a second length of tubing 28 to a three-way stopcock 30. Three-way stopcock 30 may be used to selectively connect tubing 28 to various sources of irrigation or aspiration.
Adjacent the closed end 32, tubing 22 is perforated as at 34. A balloon-like tonometric catheter membrane 36 is fitted over the closed end so that the perforations 34 are enclosed, as illustrated. The tonometric catheter membrane 36 has an internal sleeve diameter at 38 which forms a tight fit with tubing 22.
The preferred form of tonometric catheter membrane is "25 polydimethylsiloxane elastomer. The membrane may be sealed to the tubing 22 with appropriate adhesive so that the tonometric catheter membrane is sealed in a closed relationship to the outer wall of tubing 22, thereby forming a sampling chamber 40 adjacent closed end 32. The tonometric catheter membrane has a certain elasticity to allow the membrane to expand when filled with an aspirating liquid in order to contact the wall of the organ under examination, as will be explained below.
The membrane 36 is preferably constructed such that at least a portion of it is selectively permeable to the gas or fluid property of interest. In a preferre! embodiment, it is selectively permeable to. hydrogen, oxygen, or H+ so that pH, pc, 2 and/or pO 2 can be measured. It is also preferably ir=ermeable to other materials that would interfere with the desired measurements, such as other gases, proteins, and the like. In a highly preferred embodiment, an ion-selective mebrane is employed.
Bonded to either the inner wall or the outer wall of tubing 22 are one or more sensors 42 for detecting a property indicative of pH and/or temperature. Two such sensors are illustrated in Figure 1, bonded to the outside wall of tubing 22 with suitable adhesive. Figures 2A and 2B illustrate two alternate means of sensor attachment, Figure 2A illustrating the sensor attached to the inner wall of tubing 22 and Figure 2B illustrating the sensor attached to the outer wall of tubing 22.
In a preferred embodiment, at least a portion of the tubing, but not all of it, is made of a CO 2 impermeable material, S* such as polyester elastomers derived from the reaction of S dinethylterephtalate *1,4-butanediol and a -hydro- Q -hydroxypoly (oxytetramethylene). In a highly preferred embodiment, this is a material such as Hytril, sold by DuPont.
20 For purposes of sensing temperature, thermistor devices are presently preferred. For sensing properties indicative of pH chemically responsive field effect transistors or "Chemfets" may be employed. In this regard, Chemfet sensors 44 have been illustrated in Figures 2A and 2B. Chemfet sensor 44 comprises a field effect semiconductor device 46, which is encapsulated in a solution impervious material 48, such as a polyierized epoxy resin. The encapsulation material 48 in turn ray be encapsulated in a housing 50 (Figure 2A). Semiconductor device 46 is electrically coupled by bonding wires 52 to a terminal 54.
Suitable electrical conductors such as conductor 56 are attached to terminal 54 for electrically communicating between the Chemfet device 44 and the electronic circuitry described below in connection with Figure 9. Conductor 56 is preferably routed through tubing 22 and exits through a sealed aperture at or near the luer-lock end of tubing 22, as at 58. A more detailed description of a suitable electronic sensor ray be found in U.S.
Patent No. 4,020,830 to Johnson, entitled "Selective Chemical
-I
Sensitive FET Transducers," incorporated herein by reference. In order to allow a solution to contact the chemically sensitive surface of semiconductor device 46, tubing 22 may be provided with an aperture 60 when implementing the embodiment of Figure 2A. Such an aperture is not needed in the embodiment of Figure 2B, since the semiconductor device 46 is exposed to sampling chamber 40 by virtue of the external mounting configuratic The sampling chamber 40 can be filled with an aspiration or sampling medium that is used to absorb or otherwise provide a means for incorporating and delivering or measuring the the fluids or gases of interest. Such a medium is selected depending upon many factors, including the properties of the .i fluids or gases of interest, the type of sensor 42 employed, and I the type of calibration that is necessary. Such mediums include Sbicarbonate solutions and saline solution. It might be noted S' that gases often behave as fluids and are therefore frequently considered to be fluids.
As noted above, when the sensor employed does not require frequent recalibration, the need for the sampling chamber 40 to be in communication with the proximate end of the tonometric catheter (that remains outside the patient) may be eliminated since no aspiration is needed. However, in many instances such communication may still be desirable as aspiration may be required to calibrate the sensor or sensors, to replace the aspirating or sampling medium with a fresh medium, and to incorporate the gas or gases of interest.
Another embodiment of the tonometric catheter is illustrated in Figures 4, 4A and 4B. As illustrated, the tonometric catheter is appropriately configured to also serve ai a nasogastric sump, either with or without gastric suction. With reference to Figure 4, the tonometric catheter 20a comprises a multipassage tubing 62 which defines three individual noncommunicating (between each other) passageways or lumens, an air lumen 64, an optional suction lumen 66 and a tonometric catheter lumen 68. A tonometric catheter membrane, similar to that previously described, is attached at an intermediate
I:
lccation on tubing 62, allowing a portion of the tubing to extend beyond the end of membrane 36 to define the nasogastric sump Tubing 62 is provided with a plurality of perforations 72 which ccununicate between tonometric catheter lumen 68 and the sampling chamber 40 defined by membrane 36. If desired, one or more sensors 42 can be included in accordance with the above teachings, in which case a suitable conductor 56 may be routed thorough tonometric catheter lumen 68 to exit at sealed aperture 58.
The nasogastric sump portion 70 is suitably provided with a plurality of openings 74 through which the stomach may be aspirated.
the opposite end of tubing 62 the tubing splits to S form three separate connections. Air lumen 64 communicates with air lumen passageway 76, suction lumen connects with suction lumen passageway 78 and tonometric catheter lumen 68 communicates with tonometric catheter lumen passageway 80. The tonometric catheter lumen passageway is fitted with three-way stopcock similar in function and purpose to the three-way stopcock described in connection with Figure 1. If desired, a quick connect fitting 82 may be used to couple the suction lumen passageway 78 with an aspiration source. As illustrated, the c-uick connect fitting preferably has angularly cut ends and a slightly enlarged midsection, making it easy to insert into tie end of passageway 78 and also into the aspiration hose coupling S(not shown). The enlarged midsection helps form a seal with the adjoining passageways. Preferably the quick connect fitting is fabricated of disposable plastic.
Yet another embodiment of the tonometric catheter is illustrated in Figures 5 and 5A. This embodiment is a multiple tonometric catheter embodiment employing a tubing 84 having a plurality of passageways or lumen as shown in the cross-sectional view of Figure 5A. Specifically, tubing 84 includes an air lumen 86a which communicates with the endmost tonometric catheter 36a and three additional tonometric catheter lumens 86b, 86c and 86d, which communicate respectively with tonometric catheters 36b, 36c and 36d. As with the other embodiments, each V~r\Bj llll tonometric catheter may be provided with one more sensors such as sensors 42. A radiopaque tungsten plug 88 is positioned within each of the three tonometric catheter lumen 86b, 86c and 86d adjacent the distal end of each tonometric catheter, serving to block the remainder of the tonometric catheter lumen passageway and thereby ensuring that fluid pressure introduced into each tonometric catheter lumen will cause the associated tonometric catheter to balloon outwardly as required during use.
Similarly, a radiopague tungsten rod 90 is fitted as a plug in the end of air lumen 86a, serving to terminate the end of the air lumen passageway. Being radiopaque, the tungsten plugs and tungsten rod aid in properly positioning the tonometric catheters by being visible under fluoroscope or x-ray. In addition, if Sdesired, tubing 84 can be provided with a radiopaque stripe along 5 all or part of its length.
At the proximal end of tubing 84 the lumen 86a-86d S diverge to define four separate tubes 92a-92d. Each tube is fitted with a three-way stopcock similar to those described above. Each sampling connector may optionally be coded numerically by color, etc. While four approximately equally spaced tonometric catheters have been illustrated in Figure 5, it will be understood that the invention can be modified to include a greater or fewer number of tonometric catheters at different spacing as required for a particular application. It will also be understood that some or all of the tonometric catheters can include one or more sensors coupled to conductors 56, each preferably routed through the corresponding lumen passageway.
Referring now to Figure 9, a suitable electronic monitoring circuit will now be described. In Figure 9 CHEMFET semiconductor device 46 has been shown schematically by the equivalent circuit model enclosed in dotted lines. The device 46 thus comprises drain electrode 150, source electrode 152 and reference electrode 154. The chemically selective system, such as a membrane system is depicted diagrammatically at 156. The substrate is grounded as at 158.
Source electrode 154 is coupled to an input lead of operational amplifier 160 which includes feedback network 11 diagrammatically depicted at 162. Operaticnal amplifier 160 senses the drain source current flowing through device 46 and ccnverts this signal into a voltage signal vbich is output on lead 164. The drain source current changes in accordance with ctanges in the chemical system under test. More specifically, as the pCO 2 level changes in the fluid exposed to device 46, the drain source current changes accordingly. Hence the output vcltage signal on lead 164 is likewise an indication of the pCO 2 level of the organ under test. This voltage signal on lead 164 is coupled to an input of comparator 166 which also receives a reference voltage Vref, which may be supplied using a voltage divider network (not shown) or which may alternatively be provided by a digitally controlled voltage source 168. The output of comparator 166 is fed to reference electrode 154 to .15 provide a stable reference bias voltage. If a digitally controlled voltage source is used, this reference voltage can be adjusted and calibrated by a computer circuit yet to be discussed. The voltage signal on lead 164 is also fed to an analog to digital convertor 170, which is in turn coupled to a 20 microprocessor-based microcomputer 172.
SIn order to automatically determine the pH of the wall of the hollow viscous organ under test, a separate gas analyzer sensor 174 is used to determine the bicarbonate concentration in the arterial blood of the patient. The output of sensor 174 is 5 coupled through analog to digital convertor 176 to icrocomputer 172. Microcomputer 172 is preprogrammed to calculate the pH of the organ wall using the values provided by analog to digital convertors 170 and 176. Conversion of pCO 2 =easurements can be converted into pH measurements automatically by microcomputer 172 using various equations and references well-known in the art.
Although many different types of output devices may be employed, strip chart recorder 178 and CRT monitor 180 have been illustrated. Strip chart recorder 178 and monitor 180 are coupled as output devices to microcomputer 172. Strip chart recorder 178 offers the advantage of developing an easily readable, permanent record of the fluctuations in organ wall pH.
Monitor 180 offers the advantage of providing digital readout of the pH value as well as displaying the upper and lower excursions cf pH fluctuation. If desired, microcorputer 172 can be preprogrammed using keyboard 182 to compare the instantaneous pH value with doctor-selected upper and lower alarm, limits. If the measured instantaneous pH fluctuates outside those limits, Eicrocomputer 172 can sound an alarm to alert hospital staff.
While a single semiconductor device 46 has been illustrated in conjunction with the electronic circuit of Figure 9, the circuit may be readily adapted for use with a plurality of semiconductor devices in order to measure the pH at different locations substantially simultaneously. In such an embodiment, the data coming' from each sensor can be fed to a separate I/O port of microcomputer 172. In the alternative, a single I/O port can be used with the individual input signals being time multiplexed.
As an alternative to electronic pH sensors, the invention may also be practiced using optical sensor technology.
Referring to Figure 10, the presently preferred optical sensor embodiment uses a first fiber optic cable 94 which is optically coupled through a series of lenses 96, selectable color filters 98 and heat absorber 100 to an illumination source 102, such as a 100 watt tungsten-halogen lamp. Fiber optic cable 94 is routed through the tonometric catheter lumen in a fashion '2 similar to the conductor 56 of the above-described embodiments, Swith the end thereof protruding through the tubing and into the sampling chamber 40. A second fiber optic cable 104 is routed parallel to the first fiber optic cable 94, with one end protruding through the tubing and held in place adjacent the enrd of first cable 94 with a collar 106. Collar 106 may be adhesively bonded to the outside wall of the tubing. The opposite end of second fiber optic cable 104 is positioned for optically coupling with a phototransistor 108 which is electrically connected to an operational amplifier circuit 110.
The operational amplifier circuit can be coupled to an analog to digital converter, such as A/D converter 170 of Figure 7.
13 In use, fiber optic cable 94 illuminates a region within the sampling chamber 40 which is filled with a sampling fluid containing a colorimetric pH indicator. The illumination from fiber optic cable 94 reflects from the zolecules suspended in the pH indicator solution, with some of the reflected illumination passing back through second fiber optic cable 104 to the phototransistor. By selecting the appropriate filter 98, a monochromatic illumination or illumination of otherwise known spectral content is employed to illuminate the colorimetric pH indicator solution. When the color of the filtered illumination ratches that of the indicator, the illumination is absorbed and a low illumination signal is received at the phototransistor. When a pH change causes a color change in the indicator away from the color of the filtered illumination, more illumination is reflected back to the phototransistor, with an attendant increase in detected signal output. In this fashion, the proper selection cf indicator dye and illumination filtration can be used to detect pH ranges. For a further description of fiber optic pH sensor technology, refer to G. G. Vurek "A Fiber Optic pCO 2 :'20 Sensor," Annals of Biomedical Engineering, Vol. 11, pp. 499-510, 1983, which is available from Pergamon Press, Ltd., and is expressly incorporated herein by reference.
While the preferred embodiments have been disclosed in connection with monitoring of the gastrointestinal tract and tle 25 urinary and ureteric tracts it will be appreciated that its principles are applicable to other hollow internal organs to monitor pH and hence perfusion of those organs. Also while several presently preferred detailed constructions for tonometric catheters have been disclosed, it will be appreciated that other constructions may be developed which are equally suitable. The disclosed constructions are presently preferred for the reason that they are readily fabricated using existing available r-aterials. Other embodiments may include other, but equivalent Imaterials for the tonometric catheter membrane and/or connective tubing. They may also differ in the specific fabrication details. As an example, the sampling chamber may be eccentric rather than symmetric about the connective tubing.
In still another embodiment, conventional gas analyzers may be employed externally. A device such as that shown in Figure 1 may be used in combination with a pump or aspiration means (not shown) for continuous or regular intermittent S aspiration of a sample of the aspirating liquid or medium that is used to fill the sampling chamber 40. The sample removed by pump or aspiration means via attachment to the luer-lock 24 can be optionally designed so that the sample aspira'ted at each sampling interval can be brought in contact with an exterior, separate gas analyzing means or sensor (not shown) to determine the pH, p0 2 1 PCO 2 and/or the like, of the sample. Such automatic sampling can be conducted employing a system as shown in Figure 12. In the assembly a sampling system employs a personal computer to conduct evaluations and analysis of the samples withdrawn from the IStonometric catheter 299.
Pump 203 is loaded with the sampling or aspirating .:medium such as saline. Next, valve 201 is activated to withdraw a desired amount of the sampling fluid. The valve 201 is :deactivated and pump 203 is used to enforce the sampling chamber *..0of the tonometric catheter 299 using a calibrated amount or optionally a pressure transducer 215. The sampling fluid or .medium is allowed to come to equilibrium with the wall of the organ or area of interest. Next the "dead space," the area of the lumen filled with the sampling fluid that is not in equilibrium, is removed by activating valve 205, activating *.pump 207, activating valve 209 and infusing pump 207; the waste 219 is discarded. A sample for analysis is then withdrawn by deactivating valve 209, activating pump 207 to then deliver t-he sampling to a gas analyzer (not showny that provides data from the sample to the PC 217, and the evaluation is conducted as described herein.
The sample gas analyzer or a separate gas analyzer may be employed to determine the bicarbonate concentration in the arterial blood of the patient, as described above.
Another embodiment of the tono~etric catheter is illustrated in Figures 11 and 11A. As illustrated, the tonometric catheter is appropriately configured to also serve as a urinary or ureteric catheter, either with cr without suction, which optionally employs sensors. With reference to Figures 11 and 11A, the tonometric catheter 220 comprises a multipassage tubing 262 which defines three individual noncommunicating (between each other) passageways or lumens, an optional air or irrigation lumen 264, a drainage or suction lumen 266 and a tonometric catheter lumen 268. A tonometric catheter membrane, similar to that previously described, is attached at a distal location on tubing 262, allowing an intermediate portion of the tubing not extending beyond the end of membrane 236 to define the uretary or uretary catheter 270. Tubing 262 is provided with a plurality of perforations 272 which conmunicate between tonometric catheter lumen 268 and the sarpling chamber 240 defined by membrane 236. If desired, one or rore sensors 242 can 15 be included in accordance with the above teachings, in which case a suitable conductor 256 may be routed through tonometric catheter lumen 268 to exit at sealed aperture 258.
The urinary catheter or ureteric catheter portion 270 S. is suitably provided with a plurality of openings 274 through 20 which the bladder or ureters may be aspirated or irrigated.
At the opposite end of tubing 262 the tubing splits to form three separate connections. Air or irrigation lumen 264 optionally communicates with air lumen passageway 276, urinary lumen connects with suction or drainage lumen passageway 278 and 25 tonometric catheter lumen 268 communicates with tonometric catheter lumen passageway 280. The tonometric catheter lumen passageway is fitted with three-way stopcock 230, similar in function and purpose to the three-way stopcock 30 described in connection with Figure 1. If desired, a quick connect fitting 82 as seen in Figure 4 may be used to couple the suction urinary passageway 278 with an aspiration source. As illustrated, the quick connect fitting preferably has angularly cut ends and a slightly enlarged midsection, making it easy to insert into the end of passageway 278 and also into the aspiration hose coupling (not shown). The enlarged midsection helps form a seal with the adjoining passageways. Preferably the quick connect fitting is fabricated of disposable plastic.
Yet another embodiment of the urinary catheter/tonometric catheter combination illustrated in .gu;res 11 and 11A may employ a multiple tonometric catheter embodiment employing a tubing having a plurality of passageways cr lumen as shown in the cross-sectional view of Figure In another embodiment of the present invention, a tonometric catheter may be adopted to deliver a pharmaceutically-active agent, either for systemic, local or topical activity, or a combination thereof. For example, an additional lumen may be added such as that and for irrigation or aspiration, to deliver the active. For example, the irrigation/aspiration lumen 264 shown in Figure 11 and 11A, may te used to deliver an active agent. In another embodiment, a portion of the device may be modified so as to provide sustained release of the active agent of interest.
Thus, for example, the problems of nosacomial infection associated with catheter insertion can be overcome by Incorporating an antimicrobial into at least a portion of the polymeric material used to manufacture the tonometric catheter, -0 cr by coating at least a portion of the device with a sustained release composition, or by delivering the antimicrobial via the tonometric catheter. Such modifications are well known to those skilled in the art. See U.S. Patent No. 4,677,143, incorporated herein by reference.
25 Classes of useful agents include antimicrobial agents, .nsteroidal anti-inflammatory agents, topical anesthetics, topical vasodialators, metabolic suppressants, and other agents that could be delivered for absorption at th sites of the tonometric catheter.
Accordingly, while several preferred embodiments of the invention have been disclosed, it will be appreciated that principles of the invention, as set forth in the following claims, are applicable to other embodiments.
17 Throughout this specification, unless the context requires otherwise, the word "comprise", or variations such as "comprises" or "comprising", will be understood to imply the inclusion of a stated element or integer or group of elements or integers but not the exclusion of any other element or integer or group of elements or integers.
ee s ee 950629,p;Xopcukay,4062-93.div, 17 II I
Claims (2)
18- THE CLAIMS DEFINING THE INVENTION ARE AS FOLLOWS: 1. A tonometric catheter and secondary apparatus for measuring a liquid fluid or gaseous fluid property indicative of the condition of an internal organ of a human or other mammal in vivo, comprising: an elongated tube having a tonometric catheter lumen extending longitudinally therethrough, said tube being composed of a first elastomeric material that is substantially impermeable to one or more liquid fluids or gaseous fluids of interest, said fluids of interest including oxygen gases and carbon dioxide gases; at least one walled sampling chamber on said tube in fluid communication with the interior of said tonometric catheter lumen, said walled sampling chamber being defined by a balloon member generally surrounding a portion of said tube and sealingly interconnected therewith, the wall of said balloon member being composed of a second material that is freely and selectively permeable to said one or more liquid fluids or gaseous fluids of interest, said second material being substantially impermeable to other liquid fluids or gaseous fluids, and said balloon member being inflated for forming an interior space between said balloon member and said tonometric catheter lumen and for selectively positioning a portion of said 25 balloon member substantially in direct contact with a wall portion of the internal organ in order to allow said one or more liquid fluids or gaseous fluids of interest from the tissue of the wall portion of the internal organ to permeate into said sampling chamber, with said tube extending to a position outside of the body of the human or other mammal, and with said tonometric catheter lumen providing fluid communication between said sampling chamber and the outside of the body of the human or other mammal; sensor means for sensing the level of at least one of said liquid fluids or gaseous fluids of interest from the tissue of the wall portion of the internal organ present within said I I 11 1, I II 1
19- sampling chamber, said sensor means being disposed within said sampling chamber; and said secondary apparatus including a second lumen extending longitudinally through said tube and being adapted for Sthe delivery or draining of a liquid or gaseous fluid to or from the internal organ. 2. An apparatus according to claim I, which additionally includes a temperature sensor disposed within said sampling chamber. 3. An apparatus according to claim 1, wherein said sensor means includes a chemically sensitive electronic transducer. 4. An ,nparatus according to claim i, wherein said sensor means includes a chemically sensitive electronic transducer and :a temperature sensor both disposed within said sampling chamber. 5. An apparatus according to claim 1, wherein said sensor means includes a chemically sensitive field effect transistor S•transducer. 6. An apparatus according to claim I, wherein said sensor means includes a chemically sensitive field effect transistor 25 transducer and a temperature sensor both disposed within said sampling chamber. I 7. An apparatus according to claim 1, wherein said sensor means generates an electrical signal which is conveyed by a wire extending through said lumen to the outside of the body of the human or other mammal. 8. An apparatus according to claim 1, wherein said sensor means includes an optical sensor. r L 1 i t .I l; i II 1 I S An apparatus according to claim 1, wherein said sensor means includes means for sensing the level of pCO.. 10. An apparatus according to claim 1, wherein said sensor means includes means for sensing the level of pO. 11. An apparatus according to claim 1, wherein at least a portion of the tonometric catheter lumen is composed of a polyester elastomer derived from the reaction of dimethylterephtalate 1,4-butanediol and a-hydro-Q-hydroxypoly 'oxytetramethylene). 12. An apparatus according to claim 1, wherein said sensor means generates a signal, and said apparatus includes means for sending said signal to the outside of the body of the human or other mammal. e 13. An apparatus according to claim 1, wherein said secondary apparatus is a gastrointestinal sump means for the delivery or S.draining of a liquid or gaseous fluid to or from an internal organ of the gastrointestinal tract. 14. An apparatus according to claim 1, wherein said secondary S: 25 apparatus is a nasogastric sump apparatus. 15. An apparatus according to claim 1, wherein said secondary apparatus is a urinary catheter apparatus. e 16. An apparatus according to claim 1, wherein said secondary apparatus is a feeding tube apparatus. oi i I i I I t I IK I 9 -21- 17. An apparatus according to claim 1, wherein said second lumen extends longitudinally to a distal location beyond that of said tonometric catheter lumen and beyond that of said sampling chamber in order to be longitudinally spaced therefrom, said second lumen including means at its distal end for providing liquid or gaseous fluid communication between the internal organ and the interior of said second lumen. Dated this 18th day of November, 1997 MOUNTPELIER INVESTMENTS S.A. By its Patent Attorneys DAVIES COLLISON CAVE a AMSIAC A tonometric catheter apparatus (20) and method for sampling of a fluid or gas property of interest in an ir., al organ. The tonometric catheter (20) assists in early detection of the problems of stress ulceration and/or intestinal ischemia. The tonometric catheter (20) has one or more sampling chambers (20) for introduction into an internal organ or an area adjacent thereto. Preferably the wall (36) of tbh sampling chamber (40) is freely permeable to the gas or fluid of interest, but is poorly permeable to other gases or fluids. The method is accomplished by introducing the catheter into the organ such that the sampling chamber is disposed at a portion of the wall of the organ. The sampling chamber is left in position at the wall of the organ for a time sufficient to allow the fluid or gas of interest to diffuse into the sampling chamber. The concentration of the fluid or gas of interest is analyzed. e ee* 930610,p: \opcr\kay,tonometdiv,28
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23728788A | 1988-08-26 | 1988-08-26 | |
US237287 | 1988-08-26 | ||
US38070689A | 1989-07-13 | 1989-07-13 | |
US380706 | 1989-07-13 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU40162/93A Division AU658067B2 (en) | 1988-08-26 | 1993-06-10 | A tonometric catheter apparatus, an analyzing apparatus and methods |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2332295A AU2332295A (en) | 1995-09-14 |
AU687554B2 true AU687554B2 (en) | 1998-02-26 |
Family
ID=26930521
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU42086/89A Ceased AU634979B2 (en) | 1988-08-26 | 1989-08-24 | Remote sensing tonometric catheter apparatus and method |
AU23322/95A Ceased AU687554B2 (en) | 1988-08-26 | 1995-06-29 | An analyzing apparatus and method |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU42086/89A Ceased AU634979B2 (en) | 1988-08-26 | 1989-08-24 | Remote sensing tonometric catheter apparatus and method |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0386218B1 (en) |
JP (2) | JP2954249B2 (en) |
KR (1) | KR0147309B1 (en) |
AT (1) | ATE132719T1 (en) |
AU (2) | AU634979B2 (en) |
DE (1) | DE68925417T2 (en) |
DK (1) | DK101790A (en) |
FI (1) | FI902067A0 (en) |
WO (1) | WO1990001893A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9127390D0 (en) * | 1991-12-24 | 1992-02-19 | Medicina Ltd | Gastric probe |
FI96379C (en) * | 1992-10-16 | 1996-06-25 | Instrumentarium Oy | Method and apparatus for analyzing a sample |
SE9601369D0 (en) * | 1996-04-11 | 1996-04-11 | Kjell Alving | New device and method |
NL1003533C2 (en) * | 1996-07-08 | 1998-01-12 | Groningen Acad Ziekenhuis | Method for determining the acidity in the mucous membrane of the stomach or of the gastrointestinal tract. |
US6125293A (en) * | 1996-07-08 | 2000-09-26 | Academisch Ziekenhuis Groningen | Method for determining the pH in the mucosa of the stomach or the gastrointestinal tract |
FI104461B (en) * | 1998-03-13 | 2000-02-15 | Instrumentarium Oy | Tonometric measuring probe and measuring procedure |
US6402689B1 (en) | 1998-09-30 | 2002-06-11 | Sicel Technologies, Inc. | Methods, systems, and associated implantable devices for dynamic monitoring of physiological and biological properties of tumors |
SE9803375D0 (en) * | 1998-10-06 | 1998-10-06 | A & Science Invest Ab | Method and apparatus for measuring intestinal potential difference |
JP3981328B2 (en) | 2000-11-09 | 2007-09-26 | サイセル・テクノロジーズ,インコーポレイテッド | Method, circuit, and composition of matter for detecting in vivo biomolecule concentrates using fluorescent tags |
US7011814B2 (en) | 2001-04-23 | 2006-03-14 | Sicel Technologies, Inc. | Systems, methods and devices for in vivo monitoring of a localized response via a radiolabeled analyte in a subject |
US7557353B2 (en) | 2001-11-30 | 2009-07-07 | Sicel Technologies, Inc. | Single-use external dosimeters for use in radiation therapies |
US7510699B2 (en) | 2003-02-19 | 2009-03-31 | Sicel Technologies, Inc. | In vivo fluorescence sensors, systems, and related methods operating in conjunction with fluorescent analytes |
WO2018180229A1 (en) * | 2017-03-30 | 2018-10-04 | テルモ株式会社 | Oxygen measurement device and oxygen measurement system |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4265249A (en) * | 1977-07-29 | 1981-05-05 | Dr. E. Fresenius Chemisch Pharmazeutisch Industrie Kg | Catheter device and system for continuous chemical analysis of body fluids in vivo |
US4643192A (en) * | 1982-03-22 | 1987-02-17 | Regents Of The University Of Michigan | Hollow viscus tonometry |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3480003A (en) * | 1967-02-03 | 1969-11-25 | Battelle Development Corp | Apparatus for measuring esophageal motility |
US4020830A (en) * | 1975-03-12 | 1977-05-03 | The University Of Utah | Selective chemical sensitive FET transducers |
GB1527801A (en) * | 1976-07-21 | 1978-10-11 | Rolfe P | Catheters |
US4273636A (en) * | 1977-05-26 | 1981-06-16 | Kiyoo Shimada | Selective chemical sensitive field effect transistor transducers |
JPS6012802B2 (en) * | 1978-07-13 | 1985-04-03 | 三菱電機株式会社 | How to assemble the antenna device |
US4338174A (en) * | 1979-01-08 | 1982-07-06 | Mcneilab, Inc. | Electrochemical sensor with temperature compensation means |
US4381001A (en) * | 1979-07-09 | 1983-04-26 | Shaw Jr Seth T | IUD Arrangement |
NL8001420A (en) * | 1980-03-10 | 1981-10-01 | Cordis Europ | ELECTRODE COMPOSITIVE COMPOSITE, FOR AN ELECTROCHEMICAL MEASUREMENT, IN PARTICULAR AN ISFET-CONSTRUCTED COMPOSITION, AND METHOD FOR MANUFACTURING THE ASSEMBLY. |
JPS56128131A (en) * | 1980-03-14 | 1981-10-07 | Olympus Optical Co | Ph measuring apparatus |
US4502490A (en) * | 1980-10-28 | 1985-03-05 | Antec Systems Limited | Patient monitoring equipment, probe for use therewith, and method of measuring anesthesia based on oesophagal contractions |
US4432366A (en) * | 1981-11-27 | 1984-02-21 | Cordis Corporation | Reference electrode catheter |
JPS59171537A (en) * | 1983-03-17 | 1984-09-28 | 三菱レイヨン株式会社 | Method and apparatus for measuring gas partial pressure in living body |
US4727730A (en) * | 1986-07-10 | 1988-03-01 | Medex, Inc. | Integrated optic system for monitoring blood pressure |
JPS6462119A (en) * | 1987-08-31 | 1989-03-08 | Nec Corp | Intracoelomic examination apparatus |
EP0309214A3 (en) * | 1987-09-22 | 1990-03-14 | BAXTER INTERNATIONAL INC. (a Delaware corporation) | Fiber optical probe connector for physiologic measurement devices |
-
1989
- 1989-08-24 AU AU42086/89A patent/AU634979B2/en not_active Ceased
- 1989-08-24 DE DE68925417T patent/DE68925417T2/en not_active Expired - Lifetime
- 1989-08-24 WO PCT/US1989/003659 patent/WO1990001893A1/en active IP Right Grant
- 1989-08-24 JP JP1509364A patent/JP2954249B2/en not_active Expired - Lifetime
- 1989-08-24 EP EP89910276A patent/EP0386218B1/en not_active Expired - Lifetime
- 1989-08-24 KR KR1019900700853A patent/KR0147309B1/en not_active IP Right Cessation
- 1989-08-24 AT AT89910276T patent/ATE132719T1/en not_active IP Right Cessation
-
1990
- 1990-04-25 FI FI902067A patent/FI902067A0/en not_active Application Discontinuation
- 1990-04-25 DK DK101790A patent/DK101790A/en not_active Application Discontinuation
-
1993
- 1993-10-08 JP JP25314093A patent/JP3167845B2/en not_active Expired - Lifetime
-
1995
- 1995-06-29 AU AU23322/95A patent/AU687554B2/en not_active Ceased
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4265249A (en) * | 1977-07-29 | 1981-05-05 | Dr. E. Fresenius Chemisch Pharmazeutisch Industrie Kg | Catheter device and system for continuous chemical analysis of body fluids in vivo |
US4643192A (en) * | 1982-03-22 | 1987-02-17 | Regents Of The University Of Michigan | Hollow viscus tonometry |
Also Published As
Publication number | Publication date |
---|---|
AU4208689A (en) | 1990-03-23 |
AU634979B2 (en) | 1993-03-11 |
EP0386218B1 (en) | 1996-01-10 |
ATE132719T1 (en) | 1996-01-15 |
FI902067A0 (en) | 1990-04-25 |
WO1990001893A1 (en) | 1990-03-08 |
EP0386218A1 (en) | 1990-09-12 |
KR0147309B1 (en) | 1998-08-01 |
JPH06237935A (en) | 1994-08-30 |
KR900701213A (en) | 1990-12-01 |
DE68925417D1 (en) | 1996-02-22 |
DE68925417T2 (en) | 1996-08-01 |
DK101790D0 (en) | 1990-04-25 |
JP3167845B2 (en) | 2001-05-21 |
JPH03502064A (en) | 1991-05-16 |
DK101790A (en) | 1990-06-25 |
EP0386218A4 (en) | 1991-03-20 |
JP2954249B2 (en) | 1999-09-27 |
AU2332295A (en) | 1995-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5456251A (en) | Remote sensing tonometric catheter apparatus and method | |
US5186172A (en) | Remote sensing tonometric catheter apparatus | |
US5174290A (en) | Tonometric catheter combination | |
US6010453A (en) | Tonometric catheter combination | |
US5415165A (en) | Tonometric catheter combination | |
US5433216A (en) | Intra-abdominal pressure measurement apparatus and method | |
US5788631A (en) | Hollow viscus and solid organ tonometry | |
AU687554B2 (en) | An analyzing apparatus and method | |
US5526809A (en) | Hollow viscous and soild organ tonometry | |
CA2161087A1 (en) | Air tonometry measurement of intraluminal gastrointestinal pco2/po2 | |
US6238339B1 (en) | Remote sensing tonometric catheter apparatus and method | |
AU663609B2 (en) | Tonometric catheter combination | |
EP0690695B1 (en) | Remote sensing tonometric catheter apparatus | |
CA1241584A (en) | Hollow viscus tonometry | |
AU658067B2 (en) | A tonometric catheter apparatus, an analyzing apparatus and methods | |
CA1335708C (en) | Tonometric catheter combination |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |